AAAAAA

   
Results: 1-25 | 26-50 | 51-63 |
Results: 51-63/63

Authors: Hughes, GRV
Citation: Grv. Hughes, The antiphospholipid syndrome and 'multiple sclerosis', LUPUS, 8(2), 1999, pp. 89-89

Authors: Mahmud, T Hughes, GRV
Citation: T. Mahmud et Grv. Hughes, Intravenous immunoglobulin in the treatment of refractory adult Still's disease, J RHEUMATOL, 26(9), 1999, pp. 2067-2068

Authors: Pablos, JL Caliz, RA Carreira, PE Atsumi, T Serrano, L Amengual, O Santiago, B Khamashta, MA Hughes, GRV Gomez-Reino, JJ
Citation: Jl. Pablos et al., Risk of thrombosis in patients with antiphospholipid antibodies and factorV Leiden mutation, J RHEUMATOL, 26(3), 1999, pp. 588-590

Authors: D'Cruz, D Direskeneli, H Khamashta, M Hughes, GRV
Citation: D. D'Cruz et al., Lymphocyte activation markers and von Willebrand factor antigen in Wegener's granulomatosis: Potential markers for disease activity, J RHEUMATOL, 26(1), 1999, pp. 103-109

Authors: Nunn, ED Greenstein, B Khamashta, M Hughes, GRV
Citation: Ed. Nunn et al., Evidence for sexual dimorphism of estrogen receptors in hypothalamus and thymus of neonatal and immature Wistar rats, INT J IMMUN, 21(12), 1999, pp. 869-877

Authors: Cervera, R Khamashta, MA Font, J Sebastiani, GD Gil, A Lavilla, P Aydintug, AO Jedryka-Goral, A de Ramon, E Fernandez-Nebro, A Galeazzi, M Haga, HJ Mathieu, A Houssiau, F Ruiz-Irastorza, G Ingelmo, M Hughes, GRV
Citation: R. Cervera et al., Morbidity and mortality in systemic lupus erythematosus during a 5-year period - A multicenter prospective study of 1,000 patients, MEDICINE, 78(3), 1999, pp. 167-175

Authors: D'Cruz, DP Keser, G Direskeneli, H Khamashta, MA Hughes, GRV
Citation: Dp. D'Cruz et al., Anti-endothelial cell antibodies in systemic vasculitis and systemic lupuserythematosus (SLE): effects of heat inactivation on binding and specificity, CLIN EXP IM, 115(3), 1999, pp. 567-570

Authors: Wilson, WA Gharavi, AE Koike, T Lockshin, MD Branch, DW Piette, JC Brey, R Derksen, R Harris, EN Hughes, GRV Triplett, DA Khamashta, MA
Citation: Wa. Wilson et al., International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome - Report of an international workshop(vol 42, pg 1309, 1999), ARTH RHEUM, 42(9), 1999, pp. 1997-1997

Authors: Wilson, WA Gharavi, AE Koike, T Lockshin, MD Branch, DW Piette, JC Brey, R Derksen, R Harris, EN Hughes, GRV Triplett, DA Khamashta, MA
Citation: Wa. Wilson et al., International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome - Report of an international workshop, ARTH RHEUM, 42(7), 1999, pp. 1309-1311

Authors: Romero, FI Atsumi, T Tinahones, FJ Gomez-Zumaquero, JM Amengual, O Khamashta, MA Hughes, GRV
Citation: Fi. Romero et al., Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome, ARTH RHEUM, 42(12), 1999, pp. 2606-2611

Authors: Ichikawa, K Tsutsumi, A Atsumi, T Matsuura, E Kobayashi, S Hughes, GRV Khamashta, MA Koike, T
Citation: K. Ichikawa et al., A chimeric antibody with the human gamma 1 constant region as a putative standard for assays to detect IgG beta(2)-glycoprotein I-dependent anticardiolipin and anti-beta(2)-glycoprotein I antibodies, ARTH RHEUM, 42(11), 1999, pp. 2461-2470

Authors: Hughes, GRV Khamashta, MA
Citation: Grv. Hughes et Ma. Khamashta, Hughes syndrome: A short history of antiphospholipid syndrome, DECADE OF AUTOIMMUNITY, 1999, pp. 51-55

Authors: Bertolaccini, ML Roch, B Amengual, O Atsumi, T Khamashta, MA Hughes, GRV
Citation: Ml. Bertolaccini et al., Multiple antiphospholipid tests do not increase the diagnostic yield in antiphospholipid syndrome, BR J RHEUM, 37(11), 1998, pp. 1229-1232
Risultati: 1-25 | 26-50 | 51-63 |